72187-0102 : Orserdu 345 mg Oral Tablet, Film Coated
NDC: | 72187-0102 |
Labeler: | Stemline Therapeutics, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | ![]() |
Dosage Form: | Oral Tablet, Film Coated |
Application #: | NDA217639 |
Rev. Date: |
NDC Package Codes:
- 72187-0102-3: 30 TABLET, FILM COATED IN 1 BOTTLE (72187‑0102‑3)
Active Ingredients:
- Elacestrant
Dosage Strength:
- 345 mg
Pharmaceutical Classes:
- Breast Cancer Resistance Protein Inhibitors [MoA]
- Estrogen Receptor Antagonist [EPC]
- Estrogen Receptor Antagonists [MoA]
- P-Glycoprotein Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 72187-0101 Orserdu 86 mg Oral Tablet, Film Coated by Stemline Therapeutics, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:![NDC 72187-0102 QR Code](/images/NDC-QR/72187-0102-QR.png)
< Prev: 72187-0101Next: 72187-0401 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.